MGNX logo

MacroGenics (MGNX) Company Overview

Profile

Full Name:

MacroGenics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 10, 2013

Indexes:

Not included

Description:

MacroGenics (MGNX) is a biotechnology company focused on developing innovative cancer therapies. They create monoclonal antibodies and other treatments to target specific cancer cells, aiming to improve patient outcomes. Their research emphasizes precision medicine and collaboration with other organizations to advance cancer care.

Events Calendar

Earnings

Next earnings date:

Mar 7, 2025

Recent quarterly earnings:

Nov 5, 2024

Recent annual earnings:

Mar 7, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Nov 7, 24 JMP Securities
Market Perform
Nov 6, 24 HC Wainwright & Co.
Neutral
Sep 18, 24 HC Wainwright & Co.
Neutral
Aug 21, 24 HC Wainwright & Co.
Neutral
Aug 15, 24 Citigroup
Buy
Aug 7, 24 BMO Capital
Market Perform
Aug 1, 24 HC Wainwright & Co.
Neutral
Aug 1, 24 BTIG
Neutral
Jul 31, 24 JMP Securities
Market Outperform
Jul 31, 24 Guggenheim
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for MacroGenics?
  • Does MacroGenics pay dividends?
  • What sector is MacroGenics in?
  • What industry is MacroGenics in?
  • What country is MacroGenics based in?
  • When did MacroGenics go public?
  • Is MacroGenics in the S&P 500?
  • Is MacroGenics in the NASDAQ 100?
  • Is MacroGenics in the Dow Jones?
  • When was MacroGenics's last earnings report?
  • When does MacroGenics report earnings?
  • Should I buy MacroGenics stock now?

What is the ticker symbol for MacroGenics?

The ticker symbol for MacroGenics is NASDAQ:MGNX

Does MacroGenics pay dividends?

No, MacroGenics does not pay dividends

What sector is MacroGenics in?

MacroGenics is in the Healthcare sector

What industry is MacroGenics in?

MacroGenics is in the Biotechnology industry

What country is MacroGenics based in?

MacroGenics is headquartered in United States

When did MacroGenics go public?

MacroGenics's initial public offering (IPO) was on October 10, 2013

Is MacroGenics in the S&P 500?

No, MacroGenics is not included in the S&P 500 index

Is MacroGenics in the NASDAQ 100?

No, MacroGenics is not included in the NASDAQ 100 index

Is MacroGenics in the Dow Jones?

No, MacroGenics is not included in the Dow Jones index

When was MacroGenics's last earnings report?

MacroGenics's most recent earnings report was on Nov 5, 2024

When does MacroGenics report earnings?

The next expected earnings date for MacroGenics is Mar 7, 2025

Should I buy MacroGenics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions